Adaptimmune Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.

About ADAP

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8.

CEO

Adrian Rawcliffe

CEOAdrian Rawcliffe

Employees

506

Employees506

Headquarters

Abingdon, Oxfordshire

HeadquartersAbingdon, Oxfordshire

Founded

2014

Founded2014

Employees

506

Employees506

ADAP Key Statistics

Market cap

60.16M

Market cap60.16M

Price-Earnings ratio

-0.87

Price-Earnings ratio-0.87

Dividend yield

—

Dividend yield—

Average volume

652.90K

Average volume652.90K

High today

$0.2486

High today$0.2486

Low today

$0.23

Low today$0.23

Open price

$0.24

Open price$0.24

Volume

497.15K

Volume497.15K

52 Week high

$1.48

52 Week high$1.48

52 Week low

$0.1951

52 Week low$0.1951

Analyst ratings

50%

of 8 ratings

Buy

37.5%

Hold

50%

Sell

12.5%